QSC RESEARCH GRADE
≥99% HPLC PurityMS ConfirmedJanoshik COAIn-House SynthesisChina Warehouse
What is Hydroxychloroquine (HCQ)?
Hydroxychloroquine (HCQ) accumulates in lysosomes, raising intra-lysosomal pH and inhibiting lysosomal enzyme activity. Acts as an autophagy flux inhibitor, TLR7/9 antagonist, and immune modulator. Bulk powder for large-scale autophagy inhibition research, innate immune studies, and lysosomal biology. Research use only.
Research Applications
Autophagy Inhibition
LC3-II accumulation, p62 buildup, autolysosome blockade at large scale
TLR7/9 Signalling
Endosomal TLR blockade, IFN-α suppression, innate immune pathway
Lysosomal Biology
pH alkalisation, cathepsin activity, LAMP1/2, lysosomal membrane integrity
Autoimmune Research
Antigen presentation inhibition, MHC-II pathway, macrophage polarisation
Cancer Combination
Autophagy inhibitor in chemotherapy sensitisation — large-scale in vitro studies
Quick Specs
| Form | Raw bulk powder (crystalline/amorphous) |
| Purity | ≥99% by HPLC — every batch |
| CAS Number | 118-42-3 |
| Molecular Formula | C₁₈H₂₆ClN₃O, MW 335.9 |
| Identity | MS molecular weight confirmed — every batch |
| Compound Type | Aminoquinoline / Lysosomal Autophagy Inhibitor |
| COA | Janoshik-independent, publicly verifiable |
| Manufacture | In-house synthesis — Qingdao, China |
| Storage | Room temperature sealed | cool, dry storage |
| Shelf Life | 24 months (unopened) |

